본문 바로가기
KERD
논문KCI 등재

아토피 천식 소아에서 기관지확장제 반응과 천식 조절 및 호기 NO 농도 사이의 연관성

Relationships of bronchodilator response with asthma control and fractional exhaled nitric oxide in children with atopic asthma

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: Because bronchodilator response (BDR) is variable among asthmatic patients, there are practical limitations in using BDR to assess asthma control. We investigated the relationships of BDR with asthma control status and fractional exhaled nitric oxide (FeNO) in children with atopic asthma. Methods: One hundred ninety-one patients aged 8 to 16 years with atopic asthma were enrolled. Pulmonary function tests including BDR and FeNO were serially measured 10 times or more over 2 years when subjects were not receiving controller medications. During the last year of follow-up, the loss of asthma control was assessed in all participants. Results: We identified 114 children (60%) with at least 1 positive BDR (≥12%) over the 2-year observation period. Higher levels of BDRs and higher rates of positive BDRs were associated with lower lung function and lower methacholine PC20 (provocative concentration of methacholine causing a 20% fall in forced expiratory volume in one second). The loss of asthma control occurred in 106 of individuals (93%) who had positive BDRs, as compared to 52 of 77 (68%) with negative BDRs (P<0.001). There was no difference in FeNO levels between individuals with positive and negative BDRs. However, among children with negative BDRs, those developing the loss of asthma control had higher maximal FeNO levels and higher rates of FeNO>21 parts per billion than those who maintained asthma control (all P<0.001). Conclusion: Positive BDRs are linked to a higher probability of asthma control loss in children with atopic asthma. In addition, high FeNO is associated with asthma control loss in asthmatic children with negative BDRs.

Abstract

Purpose: Because bronchodilator response (BDR) is variable among asthmatic patients, there are practical limitations in using BDR to assess asthma control. We investigated the relationships of BDR with asthma control status and fractional exhaled nitric oxide (FeNO) in children with atopic asthma. Methods: One hundred ninety-one patients aged 8 to 16 years with atopic asthma were enrolled. Pulmonary function tests including BDR and FeNO were serially measured 10 times or more over 2 years when subjects were not receiving controller medications. During the last year of follow-up, the loss of asthma control was assessed in all participants. Results: We identified 114 children (60%) with at least 1 positive BDR (≥12%) over the 2-year observation period. Higher levels of BDRs and higher rates of positive BDRs were associated with lower lung function and lower methacholine PC20 (provocative concentration of methacholine causing a 20% fall in forced expiratory volume in one second). The loss of asthma control occurred in 106 of individuals (93%) who had positive BDRs, as compared to 52 of 77 (68%) with negative BDRs (P<0.001). There was no difference in FeNO levels between individuals with positive and negative BDRs. However, among children with negative BDRs, those developing the loss of asthma control had higher maximal FeNO levels and higher rates of FeNO>21 parts per billion than those who maintained asthma control (all P<0.001). Conclusion: Positive BDRs are linked to a higher probability of asthma control loss in children with atopic asthma. In addition, high FeNO is associated with asthma control loss in asthmatic children with negative BDRs.

참고문헌 (33)

  1. Masoli M, "The global burden of asthma: executive summary of the GINA Dissemination Committee report", Allergy, 59, pp.469~478 (2004)
  2. National Asthma Education and Prevention Program, "Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007", J Allergy Clin Immunol, 120(5 Suppl), pp.S94~S138 (2007)
  3. American Thoracic Society, "Lung function testing: selection of reference values and interpretative strategies", Am Rev Respir Dis, 144, pp.1202~1218 (1991)
  4. Kerstjens HA, "Variability of bronchodilator response and effects of inhaled corticosteroid treatment in obstructive airways disease. Dutch CNSLD Study Group", Thorax, 48, pp.722~729 (1993), Dutch CNSLD Study Group. Thorax
  5. Crapo RO, "Pulmonary-function testing", N Engl J Med, 331, pp.25~30 (1994)
  6. Strunk RC, "Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children", J Allergy Clin Immunol, 112, pp.883~892 (2003)
  7. Covar RA, "Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma", J Pediatr, 142, pp.469~475 (2003)
  8. Faul JL, "Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma", Chest, 121, pp.1414~1420 (2002)
  9. Sharma S, "Clinical predictors and outcomes of consistent bronchodilator response in the childhood asthma management program", J Allergy Clin Immunol, 122, pp.921~928.e4 (2008)
  10. Postma DS, "Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction", Am Rev Respir Dis, 134, pp.276~280 (1986)
  11. Tantisira KG, "Bronchodilation and bronchoconstriction : predictors of future lung function in childhood asthma", J Allergy Clin Immunol, 117, pp.1264~1271 (2006)
  12. Fahy JV, "Airway inflammation and remodeling in asthma", Curr Opin Pulm Med, 6, pp.15~20 (2000)
  13. Goleva E, "Airway remodeling and lack of bronchodilator response in steroid-resistant asthma", J Allergy Clin Immunol, 120, pp.1065~1072 (2007)
  14. "National asthma education and prevention program. Expert panel report 3: guidelines for the diagnosis and management of asthma. Full report 2007"[URL]
  15. "GINA Report, Global Strategy for Asthma Management and Prevention" (2011)[URL]
  16. Hankinson JL, "Spirometric reference values from a sample of the general U.S. population", Am J Respir Crit Care Med, 159, pp.179~187 (1999)
  17. Miller MR, "Standardisation of spirometry", Eur Respir J, 26, pp.319~338 (2005)
  18. Crapo RO, "Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999", Am J Respir Crit Care Med, 161, pp.309~329 (2000)
  19. "Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999", Am J Respir Crit Care Med, 160, pp.2104~2117 (1999)
  20. Jones SL, "The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control", Am J Respir Crit Care Med, 164, pp.738~743 (2001)
  21. de Jongste JC, "Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma", Am J Respir Crit Care Med, 179, pp.93~97 (2009)
  22. Stern G, "Fluctuation phenotyping based on daily fraction of exhaled nitric oxide values in asthmatic children", J Allergy Clin Immunol, 128, pp.293~300 (2011)
  23. Woo SI, "Utility of fractional exhaled nitric oxide(F(E)NO)measurements in diagnosing asthma", Respir Med, 106, pp.1103~1109 (2012)
  24. Kharitonov SA, "Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients", Am J Respir Crit Care Med, 153, pp.454~457 (1996)
  25. Silkoff PE, "Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients", Chest, 119, pp.1322~1328 (2001)
  26. 서동인, "천식 소아에서 아토피 유무가 기관지확장제 반응에 미치는 영향", Allergy Asthma & Respiratory Diseases, 21(1), pp.39~46 (2011), 대한 소아알레르기 호흡기학회
  27. Jackson DJ, "Fractional exhaled nitric oxide measurements are most closely associated with allergic sensitization in school-age children", J Allergy Clin Immunol, 124, pp.949~953 (2009)
  28. Spanier AJ, "Environmental exposures and exhaled nitric oxide in children with asthma", J Pediatr, 149, pp.220~226 (2006)
  29. Colon-Semidey AJ, "Correlation between reversibility of airway obstruction and exhaled nitric oxide levels in children with stable bronchial asthma", Pediatr Pulmonol, 30, pp.385~392 (2000)
  30. Kitch BT, "A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up", Chest, 126, pp.1875~1882 (2004)
  31. Dundas I, "Diagnostic accuracy of bronchodilator responsiveness in wheezy children", Thorax, 60, pp.13~16 (2005)
  32. Galant SP, "The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry", J Pediatr, 158, pp.953~959 (2011)
  33. Bossios A, "Rhinovirus infection and house dust mite exposure synergize in inducing bronchial epithelial cell interleukin-8 release", Clin Exp Allergy, 38, pp.1615~1626 (2008)

관련 논문AI추천

소아 천식 조절 지표로서의 기관지확장제반응의 유용성김경원, 김수연, 김윤희, 김종덕, 설인숙, 손명현대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2019 · 제7권 제2호소아 아토피천식 환자에서 메타콜린 PC20와 천식 조절 상태 사이의 연관성김헌, 윤신애, 윤지용, 한윤수대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2013 · 제1권 제1호소아 아토피 천식 환자에서 호기 NO 농도와 천식 조절 점수 및 폐기능검사 결과 사이의 연관성김정옥, 우성일, 한윤수대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2011 · 제21권 제1호소아 천식 환자에서 호기산화질소 농도와 노력성중간호기유량과의 관계유영, 김은지, 박상희, 임창훈, 임현욱, 정지태대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2016 · 제4권 제1호알레르기비염 동반 여부에 따른 소아 아토피 천식 환자의 호기산화질소 농도와 기관지 과민성이은, 박준성, 양송이, 유진호, 윤지선, 조현주, 홍수종대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2015 · 제3권 제6호소아천식에서 천식 조절 상태 평가 도구의 유용성김경원, 김규언, 김윤희, 김환수, 박영아, 손명현, 이희선, 한윤기대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2015 · 제3권 제4호

이 간행물의 다른 논문 (13건)